Three million lives: That is roughly equivalent to losing the population of Berlin, Chicago or Taipei. The scale is so staggering that it sometimes begins to feel real only in places like graveyards.
More than 100,000 people have died of Covid-19 in France. The death rate is inching up in Michigan. Morgues in some Indian cities are overflowing with corpses.
The world’s Covid-19 death toll surpassed three million on Saturday, according to a New York Times database. And as the United States and other rich nations race to vaccinate their populations, new hot spots have emerged in parts of Asia, Eastern Europe and Latin America.
The global pace of deaths is accelerating, too. After the coronavirus emerged in the Chinese city of Wuhan, the pandemic claimed a million lives in nine months. It took another four months to kill its second million, and just three months to kill a million more.
according to a New York Times tracker.
At the same time, new outbreaks are still cropping up persistently in rich countries. That has shocked millions of people — from Madrid to Los Angeles — who once expected regular life to resume in tandem with vaccine rollouts.
France, which on Thursday became the third country in Western Europe to pass 100,000 deaths, is in the throes of a third national lockdown.
France on Thursday was the third European country to pass the tragic milestone of 100,000 coronavirus deaths, as it struggles to envision a clear way out of a third wave of infections.
A deep sense of fatigue and frustration has taken root in the country over a seemingly endless cycle of coronavirus restrictions and Paris has been shrouded in gloom for months. The country entered a third national lockdown two weeks ago that has limited outdoor activities, forced nonessential shops to close, banned travel between regions and shut schools for a month.
Michigan, the worst-hit state, is reporting an average of about 50 deaths a day, twice as many as two weeks ago, along with 7,800 or so new cases.
- On April 13, 2021, U.S. health agencies called for an immediate pause in the use of Johnson & Johnson’s single-dose Covid-19 vaccine after six recipients in the United States developed a rare disorder involving blood clots within one to three weeks of vaccination.
- All 50 states, Washington, D.C. and Puerto Rico temporarily halted or recommended providers pause the use of the vaccine. The U.S. military, federally run vaccination sites and a host of private companies, including CVS, Walgreens, Rite Aid, Walmart and Publix, also paused the injections.
- Fewer than one in a million Johnson & Johnson vaccinations are now under investigation. If there is indeed a risk of blood clots from the vaccine — which has yet to be determined — that risk is extremely low. The risk of getting Covid-19 in the United States is far higher.
- The pause could complicate the nation’s vaccination efforts at a time when many states are confronting a surge in new cases and seeking to address vaccine hesitancy.
- Johnson & Johnson has also decided to delay the rollout of its vaccine in Europe amid concerns over rare blood clots, dealing another blow to Europe’s inoculation push. South Africa, devastated by a more contagious virus variant that emerged there, suspended use of the vaccine as well. Australia announced it would not purchase any doses.
The United States and parts of Western Europe bore the brunt of deaths for the first year of the pandemic. Now, the hot spots for fatalities are in regions like Eastern Europe, South Asia and Latin America.